MiMedx Group, Inc (MDXG) News
Filter MDXG News Items
MDXG News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest MDXG News From Around the Web
Below are the latest news stories about MIMEDX GROUP INC that investors may wish to consider to help them evaluate MDXG as an investment opportunity.
Q1 2023 MiMedx Group Inc Earnings CallQ1 2023 MiMedx Group Inc Earnings Call |
MDXG: 1Q:22 Financial ResultsBy John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT First Quarter 2023 Results MiMedx Group, Inc. (NASDAQ:MDXG) reported first quarter 2023 revenues of $71.7 million, representing a 22% year over year growth rate, surpassing our $64.2 million estimate. Loss from operations was ($3.4) million, negatively impacted by higher-than-expected Investigation and Restatement costs. |
MIMEDX Announces First Quarter 2023 Operating and Financial ResultsFirst Quarter Net Sales of $71.7 Million Reflect an Increase of 21.7% Over the Prior Year Period Revenue Growth & Cost Controls Help Drive Improvements in Net Loss, EBITDA & Adjusted EBITDA1 Management to Host Conference Call on Tuesday, May 2, 2023, at 5:00 PM ET MARIETTA, Ga., May 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced operating and financial results for the first quarter 2023, whi |
MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 after the market close on Tuesday, May 2, 2023. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 5:00 p.m. Eastern Time on the same day. The conference call can be accesse |
Investors in MiMedx Group (NASDAQ:MDXG) have unfortunately lost 57% over the last five yearsGenerally speaking long term investing is the way to go. But no-one is immune from buying too high. For example, after... |
MIMEDX Announces Chief Financial Officer TransitionExecutive Search UnderwayMARIETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that Peter M. Carlson, Chief Financial Officer, has decided to leave the Company to pursue other opportunities. The Company has initiated a search for its next Chief Financial Officer and Mr. Carlson will be assisting MIMEDX throughout this process to ensure a smooth transition. “In the three years P |
MIMEDX Comments on Recent Data Brief Published by Office of Inspector GeneralCompany applauds the Office of Inspector General’s (“OIG”) recommendation for the Centers for Medicare and Medicaid Services (“CMS”) to quickly address issues associated with Average Sales Price (“ASP”) reporting requirements for skin substitute productsMARIETTA, Ga., March 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today applauded the recent report published by OIG entitled, “Some Skin Substitute Manuf |
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2022 Earnings Call TranscriptMiMedx Group, Inc. (NASDAQ:MDXG) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. […] |
MiMedx Group Full Year 2022 Earnings: In Line With ExpectationsMiMedx Group ( NASDAQ:MDXG ) Full Year 2022 Results Key Financial Results Revenue: US$267.8m (up 3.6% from FY 2021... |
Institutional investors own a significant stake of 38% in MiMedx Group, Inc. (NASDAQ:MDXG)Key Insights Institutions' substantial holdings in MiMedx Group implies that they have significant influence over the... |